Mapping CD55 function -: The structure of two pathogen-binding domains at 1.7 Å

被引:53
作者
Williams, P
Chaudhry, Y
Goodfellow, IG
Billington, J
Powell, R
Spiller, OB
Evans, DJ
Lea, S
机构
[1] Univ Oxford, Dept Biochem, Mol Biophys Lab, Oxford OX1 3QU, England
[2] Univ Glasgow, Div Virol, Fac Biomed & Life Sci, Glasgow G11 5JR, Lanark, Scotland
[3] Cardiff Univ, Dept Med Biochem, Complement Biol Grp, Cardiff CF4 4XX, S Glam, Wales
关键词
D O I
10.1074/jbc.M212561200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Decay-accelerating factor (CD55), a regulator of the alternative and classical pathways of complement activation, is expressed on all serum-exposed cells. It is used by pathogens, including many enteroviruses and uropathogenic Escherichia coli, as a receptor prior to infection. We describe the x-ray structure of a pathogen-binding fragment of human CD55 at 1.7 Angstrom resolution containing two of the three domains required for regulation of human complement. We have used mutagenesis to map biological functions onto the molecule; decay-accelerating activity maps to a single face of the molecule, whereas bacterial and viral pathogens recognize a variety of different sites on CD55.
引用
收藏
页码:10691 / 10696
页数:6
相关论文
共 35 条
[1]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[2]   SOLUTION STRUCTURE OF A PAIR OF COMPLEMENT MODULES BY NUCLEAR-MAGNETIC-RESONANCE [J].
BARLOW, PN ;
STEINKASSERER, A ;
NORMAN, DG ;
KIEFFER, B ;
WILES, AP ;
SIM, RB ;
CAMPBELL, ID .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 232 (01) :268-284
[3]   SECONDARY STRUCTURE OF A COMPLEMENT CONTROL PROTEIN MODULE BY 2-DIMENSIONAL H-1-NMR [J].
BARLOW, PN ;
BARON, M ;
NORMAN, DG ;
DAY, AJ ;
WILLIS, AC ;
SIM, RB ;
CAMPBELL, ID .
BIOCHEMISTRY, 1991, 30 (04) :997-1004
[4]   Structure and distribution of modules in extracellular proteins [J].
Bork, P ;
Downing, AK ;
Kieffer, B ;
Campbell, ID .
QUARTERLY REVIEWS OF BIOPHYSICS, 1996, 29 (02) :119-167
[5]   Structure/function studies of human decay-accelerating factor [J].
Brodbeck, WG ;
Kuttner-Kondo, L ;
Mold, C ;
Medof, ME .
IMMUNOLOGY, 2000, 101 (01) :104-111
[6]   Crystallography & NMR system:: A new software suite for macromolecular structure determination [J].
Brunger, AT ;
Adams, PD ;
Clore, GM ;
DeLano, WL ;
Gros, P ;
Grosse-Kunstleve, RW ;
Jiang, JS ;
Kuszewski, J ;
Nilges, M ;
Pannu, NS ;
Read, RJ ;
Rice, LM ;
Simonson, T ;
Warren, GL .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1998, 54 :905-921
[7]   Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods [J].
delaFortelle, E ;
Bricogne, G .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :472-494
[8]   The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) [J].
Hamann, J ;
Vogel, B ;
vanSchijndel, GMW ;
vanLier, RAW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :1185-1189
[9]   Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities [J].
Harris, CL ;
Spiller, OB ;
Morgan, BP .
IMMUNOLOGY, 2000, 100 (04) :462-470
[10]  
HE Y, 2002, P NATL ACAD SCI US